Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)

Market Cap	1.81B
Revenue (ttm)	898.47M
Net Income (ttm)	71.36M
Shares Out	10.52M
EPS (ttm)	5.81
PE Ratio	29.55
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,400
Average Volume	6,860
Open	175.00
Previous Close	167.80
Day's Range	170.00 - 176.15
52-Week Range	81.10 - 177.95
Beta	0.17
RSI	63.03
Earnings Date	Aug 11, 2025

About NSE:MADHAVBAUG

Vaidya Sane Ayurved Laboratories Limited, together with its subsidiaries, distributes ayurvedic medicines and products in India. It operates through Sale of Product and Hospital Activity segments. The company sells medicines for arthritis and joint pains, cholesterol, diabetes, digestive, acidity, gastric, dyslipidemia, fever, cough, cold, general tonic, heart disease, hypertension/high blood pressure, liver, low glycemic index atta, obesity/weight management, piles and renal, skin, and wounds; and diet boxes, glow gorgeous cosmetics, health su...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1999
• Employees: 636
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MADHAVBAUG

Financial Performance

In 2024, NSE:MADHAVBAUG's revenue was 898.47 million, a decrease of -9.55% compared to the previous year's 993.31 million. Earnings were 71.36 million, an increase of 260.34%.